Impact of 2004 ISUP/WHO Classification on Bladder Cancer Grading

Overview

Journal World J Urol

Specialty Urology

Date 2015 Apr 3

PMID 25833661

Citations 12

Authors

Soum D Lokeshwar

Roberto Ruiz-Cordero

Marie C Hupe

Merce Jorda

Mark S Soloway

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine whether implementation of the 2004 WHO/ISUP bladder cancer (BCa) grading system caused a grade migration, i.e., more tumors being graded as high grade (HG).

Methods: Data on 1040 BCa cases from 668 patients treated at our institution between 2000 and 2013 and reviewed by six pathologists were evaluated: low grade (LG): 249; HG: 791; Ta: 389; T1: 214; CIS: 95; ≥T2: 342. Differences in LG or HG cases (expressed as %BCa cases/year) were analyzed by Mann-Whitney test. Correlation between the year of diagnosis and clinical/pathological parameters was evaluated by logistic regression analyses.

Results: During the study period, BCa cases diagnosed as LG significantly decreased with a corresponding increase in HG cases. Nonlinear regression analysis indicated that ~2008 was the crossover point for grade migration; %LG: 31.8 ± 4.8 (2000-2007); 14.1 ± 7.0 (2008-2013); %HG: 68.2 ± 4.8 (2000-2007); 85.9 ± 6.9 (2008-2013), P = 0.004. The grade migration was confined to Ta cases with %LG Ta cases diagnosed decreasing by 3.6-fold from 2000-2007 to 2008-2013 (P = 0.004). Univariate and multivariate analyses confirmed the grade migration following the adoption of the 2004 system (P < 0.0001). Kaplan-Meier curves showed no significant differences between the two time intervals in terms of disease progression (P > 0.05).

Conclusions: Implementation of the 2004 WHO/ISUP system caused a significant increase in pathologists grading Ta cases as HG; however, this increase did not seem to correlate with disease progression. Since LG and HG Ta tumors are treated differently, grade migration may impact the clinical management of BCa patients.

Citing Articles

Recent Advances in the Classification of Bladder Cancer - Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors.

Guo C, Shen S, Czerniak B Bladder Cancer. 2024; 9(1):1-14.

PMID: 38994481 PMC: 11181758. DOI: 10.3233/BLC-220106.

Integrins are enriched on aberrantly fucosylated tumour-derived urinary extracellular vesicles.

Islam M, Dhondt B, Syed P, Khan M, Gidwani K, Webber J J Extracell Biol. 2024; 1(10):e64.

PMID: 38939212 PMC: 11080809. DOI: 10.1002/jex2.64.

Inflection points in urology as witnessed by Mark Soloway. Part 1: bladder cancer.

Soloway M Cent European J Urol. 2023; 76(3):263-268.

PMID: 38045773 PMC: 10690384. DOI: 10.5173/ceju.2023.002E.

Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.

Lokeshwar S, Lopez M, Sarcan S, Aguilar K, Morera D, Shaheen D Cancers (Basel). 2022; 14(11).

PMID: 35681556 PMC: 9179261. DOI: 10.3390/cancers14112578.

A retrospective analysis of the correlation between AXL expression and clinical outcomes of patients with urothelial bladder carcinoma.

Wang L, Liu K, Yu J, Sun E Transl Cancer Res. 2022; 8(3):976-984.

PMID: 35116837 PMC: 8798078. DOI: 10.21037/tcr.2019.06.06.

References

Rodriguez Faba O, Gaya J, Lopez J, Capell M, de Gracia-Nieto A, Gomez Correa E . Current management of non-muscle-invasive bladder cancer. Minerva Med. 2013; 104(3):273-86. View

Epstein J, Amin M, Reuter V, Mostofi F . The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998; 22(12):1435-48. DOI: 10.1097/00000478-199812000-00001. View

Bergkvist A, Ljungqvist A, MOBERGER G . Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand. 1965; 130(4):371-8. View

Otto W, Denzinger S, Fritsche H, Burger M, Wieland W, Hofstadter F . The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer. BJU Int. 2010; 107(3):404-8. DOI: 10.1111/j.1464-410X.2010.09515.x. View

Yin H, Leong A . Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am J Clin Pathol. 2004; 121(5):679-87. DOI: 10.1309/0KAT-YHQB-JD5X-HQ8J. View

Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R . ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2012; 63(1):36-44. DOI: 10.1016/j.eururo.2012.08.061. View

Pan C, Chang Y, Chen K, Yu H, Sun C, Ho D . Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladder. J Clin Pathol. 2010; 63(10):910-5. DOI: 10.1136/jcp.2010.079764. View

Reuter V, Epstein J, Amin M, Mostofi F . The "WHO/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms": continued discussion. Hum Pathol. 1999; 30(7):879-80. DOI: 10.1016/s0046-8177(99)90153-3. View

Hansel D, Miller J, Cookson M, Chang S . Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist. Urology. 2013; 81(6):1123-30. PMC: 5224832. DOI: 10.1016/j.urology.2013.01.027. View

10.

van Rhijn B, van Leenders G, Ooms B, Kirkels W, Zlotta A, Boeve E . The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading. Eur Urol. 2009; 57(6):1052-7. DOI: 10.1016/j.eururo.2009.09.022. View

11.

Chen Z, Ding W, Xu K, Tan J, Sun C, Gou Y . The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer. PLoS One. 2012; 7(10):e47199. PMC: 3474808. DOI: 10.1371/journal.pone.0047199. View

12.

Miyamoto H, Brimo F, Schultz L, Ye H, Miller J, Fajardo D . Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Arch Pathol Lab Med. 2010; 134(8):1160-3. DOI: 10.5858/2009-0403-OA.1. View

13.

Smith Z, Christodouleas J, Keefe S, Malkowicz S, Guzzo T . Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy. BJU Int. 2013; 112(1):13-25. DOI: 10.1111/j.1464-410X.2012.11762.x. View

14.

Burger M, Denzinger S, Wieland W, Stief C, Hartmann A, Zaak D . Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?. BJU Int. 2008; 102(2):194-7. DOI: 10.1111/j.1464-410X.2008.07538.x. View

15.

Pezaro C, Liew M, Davis I . Urothelial cancers: using biology to improve outcomes. Expert Rev Anticancer Ther. 2011; 12(1):87-98. DOI: 10.1586/era.11.195. View

16.

Cao D, Vollmer R, Luly J, Jain S, Roytman T, Ferris C . Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology. 2010; 76(3):593-9. DOI: 10.1016/j.urology.2010.01.032. View

17.

Gakis G, Efstathiou J, Lerner S, Cookson M, Keegan K, Guru K . ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2012; 63(1):45-57. DOI: 10.1016/j.eururo.2012.08.009. View

18.

Gandhi N, Morales A, Lamm D . Bacillus Calmette-Guérin immunotherapy for genitourinary cancer. BJU Int. 2013; 112(3):288-97. DOI: 10.1111/j.1464-410X.2012.11754.x. View

19.

Amin M, McKenney J, Paner G, Hansel D, Grignon D, Montironi R . ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. Eur Urol. 2012; 63(1):16-35. DOI: 10.1016/j.eururo.2012.09.063. View

20.

Soloway M, Bruck D, Kim S . Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol. 2003; 170(2 Pt 1):438-41. DOI: 10.1097/01.ju.0000076621.71247.6c. View